CHINA PEPTIDESUPPLIERSINDEPENDENT INDUSTRY DIRECTORY
Peptides/Peptide CDMOs in China: Development, Manufacturing and CMC Scope

Peptide CDMO guide

Peptide CDMOs in China: Development, Manufacturing and CMC Scope

A peptide CDMO supports more than a single purchase order. The comparison should focus on the continuity between process development, analytical methods, scale-up, clinical supply, and commercial manufacturing.

CDMO versus a catalog supplier

A CDMO typically provides a project service spanning development or manufacturing activities, while a catalog supplier may primarily sell defined products or research materials. Some companies do both. A directory should classify the public evidence rather than assume that one business model excludes the other.

Look for evidence of process development, route optimization, impurity control, technology transfer, batch documentation, and project management. A generic statement that a company is a CDMO is less informative than a specific description of the stages it can support.

A useful CDMO comparison framework

Start with the stage you need: feasibility, preclinical material, clinical supply, process validation, or commercial supply. Then compare chemistry fit, modification experience, purification options, analytical depth, quality systems, facility location, and communication across time zones.

The directory's evidence score is not a quality rating. It only indicates how much relevant information is publicly reviewable. A high-disclosure profile still requires buyer due diligence and supplier confirmation.

  • Development and process chemistry
  • Scale-up and manufacturing stage
  • Analytical and impurity characterization
  • Quality agreements and technology transfer
  • Regulatory and export documentation

What to request before a serious evaluation

Request a capability deck, anonymized example documentation, quality-system overview, facility scope, relevant certifications, and a proposed development plan. The exact document set depends on intended use and jurisdiction, so procurement, quality, regulatory, and scientific teams should review the information together.